Phase II Study Of Epothilone B Analogue BMS-247550 [Ixabepilone] In Relapse And/Or Refractory Stage III Or IV Ovarian Epithelial Cancer, Following Front-Line Treatment With Platinum Plus Taxane-Based Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2018
At a glance
- Drugs Ixabepilone (Primary)
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 27 Sep 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 23 Aug 2005 New trial record.